• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们所做的所有这些筛选:功能遗传筛选如何帮助我们理解核糖体生物发生。

All these screens that we've done: how functional genetic screens have informed our understanding of ribosome biogenesis.

机构信息

Department of Genetics, Yale School of Medicine, New Haven, CT, U.S.A.

出版信息

Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230631.

DOI:10.1042/BSR20230631
PMID:37335083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10329186/
Abstract

Ribosome biogenesis is the complex and essential process that ultimately leads to the synthesis of cellular proteins. Understanding each step of this essential process is imperative to increase our understanding of basic biology, but also more critically, to provide novel therapeutic avenues for genetic and developmental diseases such as ribosomopathies and cancers which can arise when this process is impaired. In recent years, significant advances in technology have made identifying and characterizing novel human regulators of ribosome biogenesis via high-content, high-throughput screens. Additionally, screening platforms have been used to discover novel therapeutics for cancer. These screens have uncovered a wealth of knowledge regarding novel proteins involved in human ribosome biogenesis, from the regulation of the transcription of the ribosomal RNA to global protein synthesis. Specifically, comparing the discovered proteins in these screens showed interesting connections between large ribosomal subunit (LSU) maturation factors and earlier steps in ribosome biogenesis, as well as overall nucleolar integrity. In this review, a discussion of the current standing of screens for human ribosome biogenesis factors through the lens of comparing the datasets and discussing the biological implications of the areas of overlap will be combined with a look toward other technologies and how they can be adapted to discover more factors involved in ribosome synthesis, and answer other outstanding questions in the field.

摘要

核糖体生物发生是一个复杂而必要的过程,最终导致细胞蛋白质的合成。了解这个基本过程的每一步对于增加我们对基础生物学的理解是至关重要的,但更重要的是,为遗传和发育疾病(如核糖体病和癌症)提供新的治疗途径,当这个过程受损时,这些疾病就会发生。近年来,技术的重大进步使得通过高内涵、高通量筛选来鉴定和表征新型人类核糖体生物发生调节剂成为可能。此外,筛选平台也被用于发现癌症的新型治疗药物。这些筛选揭示了大量与人类核糖体生物发生相关的新型蛋白质的知识,从核糖体 RNA 的转录调控到全局蛋白质合成。具体来说,比较这些筛选中发现的蛋白质显示出大核糖体亚基(LSU)成熟因子与核糖体生物发生早期步骤以及整体核仁完整性之间的有趣联系。在这篇综述中,我们将通过比较数据集来讨论当前人类核糖体生物发生因子筛选的现状,并讨论重叠区域的生物学意义,同时还将着眼于其他技术以及如何对其进行改造以发现更多参与核糖体合成的因子,并回答该领域的其他悬而未决的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7314/10329186/c652a06b4284/bsr-43-bsr20230631-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7314/10329186/c035f4c20672/bsr-43-bsr20230631-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7314/10329186/c652a06b4284/bsr-43-bsr20230631-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7314/10329186/c035f4c20672/bsr-43-bsr20230631-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7314/10329186/c652a06b4284/bsr-43-bsr20230631-g2.jpg

相似文献

1
All these screens that we've done: how functional genetic screens have informed our understanding of ribosome biogenesis.我们所做的所有这些筛选:功能遗传筛选如何帮助我们理解核糖体生物发生。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230631.
2
Nucleolar stress: From development to cancer.核仁应激:从发育到癌症。
Semin Cell Dev Biol. 2023 Feb 28;136:64-74. doi: 10.1016/j.semcdb.2022.04.001. Epub 2022 Apr 8.
3
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.核糖体生物发生:癌症转移和治疗抵抗的核心参与者。
Cancer Res. 2022 Jul 5;82(13):2344-2353. doi: 10.1158/0008-5472.CAN-21-4087.
4
MicroRNAs and long non-coding RNAs as novel regulators of ribosome biogenesis.MicroRNAs 和长非编码 RNA 作为核糖体生物发生的新型调节因子。
Biochem Soc Trans. 2020 Apr 29;48(2):595-612. doi: 10.1042/BST20190854.
5
The Effects of Deregulated Ribosomal Biogenesis in Cancer.核糖体生物发生失调在癌症中的作用。
Biomolecules. 2023 Oct 30;13(11):1593. doi: 10.3390/biom13111593.
6
Probing the mechanisms underlying human diseases in making ribosomes.探究人类疾病在核糖体生成过程中的潜在机制。
Biochem Soc Trans. 2016 Aug 15;44(4):1035-44. doi: 10.1042/BST20160064.
7
Eukaryotic Ribosome Assembly.真核生物核糖体组装。
Annu Rev Biochem. 2019 Jun 20;88:281-306. doi: 10.1146/annurev-biochem-013118-110817. Epub 2018 Dec 19.
8
Diverse Regulators of Human Ribosome Biogenesis Discovered by Changes in Nucleolar Number.核仁数目的变化发现了调控人类核糖体生物发生的多种调节因子。
Cell Rep. 2018 Feb 13;22(7):1923-1934. doi: 10.1016/j.celrep.2018.01.056.
9
Ribosomal RNA Transcription Regulation in Breast Cancer.核糖体 RNA 转录调控在乳腺癌中的作用。
Genes (Basel). 2021 Mar 29;12(4):502. doi: 10.3390/genes12040502.
10
Ribosome assembly in eukaryotes.真核生物中的核糖体组装
Gene. 2003 Aug 14;313:17-42. doi: 10.1016/s0378-1119(03)00629-2.

引用本文的文献

1
Emergent microenvironments of nucleoli.核仁的紧急微环境。
Nucleus. 2024 Dec;15(1):2319957. doi: 10.1080/19491034.2024.2319957. Epub 2024 Mar 5.

本文引用的文献

1
Identification of an E3 ligase that targets the catalytic subunit of RNA Polymerase I upon transcription stress.鉴定出一种 E3 连接酶,它在转录应激时靶向 RNA 聚合酶 I 的催化亚基。
J Biol Chem. 2022 Dec;298(12):102690. doi: 10.1016/j.jbc.2022.102690. Epub 2022 Nov 11.
2
Human pre-60S assembly factors link rRNA transcription to pre-rRNA processing.人类60S前体组装因子将rRNA转录与前体rRNA加工联系起来。
RNA. 2022 Nov 2;29(1):82-96. doi: 10.1261/rna.079149.122.
3
Translation and natural selection of micropeptides from long non-canonical RNAs.
长非编码 RNA 来源的小肽的翻译和自然选择。
Nat Commun. 2022 Oct 31;13(1):6515. doi: 10.1038/s41467-022-34094-y.
4
Real-time imaging of RNA polymerase I activity in living human cells.实时成像活人体细胞中 RNA 聚合酶 I 的活性。
J Cell Biol. 2023 Jan 2;222(1). doi: 10.1083/jcb.202202110. Epub 2022 Oct 25.
5
Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development.核仁与核仁应激:从细胞命运决定到疾病发生。
Cells. 2022 Sep 27;11(19):3017. doi: 10.3390/cells11193017.
6
Targeting the nucleolus as a therapeutic strategy in human disease.以核仁为靶点的人类疾病治疗策略。
Trends Biochem Sci. 2023 Mar;48(3):274-287. doi: 10.1016/j.tibs.2022.09.006. Epub 2022 Oct 10.
7
A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex).一种首创的临床 G-四链体靶向药物。氟喹诺酮类药物 QQ58 向 CX-5461(Pidnarulex)的从实验室到临床的转化。
Bioorg Med Chem Lett. 2022 Dec 1;77:129016. doi: 10.1016/j.bmcl.2022.129016. Epub 2022 Oct 3.
8
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial.BMS-986158,一种溴结构域和额外末端结构域蛋白的小分子抑制剂,用于特定晚期实体瘤患者:1/2a期试验结果
Cancers (Basel). 2022 Aug 23;14(17):4079. doi: 10.3390/cancers14174079.
9
Mapping subcellular localizations of unannotated microproteins and alternative proteins with MicroID.利用 MicroID 绘制未注释的微蛋白和替代蛋白的亚细胞定位。
Mol Cell. 2022 Aug 4;82(15):2900-2911.e7. doi: 10.1016/j.molcel.2022.06.035. Epub 2022 Jul 28.
10
DHX37 and 46,XY DSD: A New Ribosomopathy?DHX37与46,XY性发育障碍:一种新的核糖体病?
Sex Dev. 2022;16(2-3):194-206. doi: 10.1159/000522004. Epub 2022 Jul 14.